Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor

Brad P. Barnett, Yousang Hwang, Martin S. Taylor, Henriette Kirchner, Paul T. Pfluger, Vincent Bernard, Yu Yi Lin, Erin M. Bowers, Chandrani Mukherjee, Woo Jin Song, Patti A. Longo, Daniel J. Leahy, Mehboob A. Hussain, Matthias H. Tschöp, Jef D. Boeke, Philip A. Cole

    Research output: Contribution to journalArticlepeer-review


    Ghrelin is a gastric peptide hormone that stimulates weight gain in vertebrates. The biological activities of ghrelin require octanoylation of the peptide on Ser3, an unusual posttranslational modification that is catalyzed by the enzyme ghrelin O-acyltransferase (GOAT). Here, we describe the design, synthesis, and characterization of GO-CoA-Tat, a peptide-based bisubstrate analog that antagonizes GOAT. GO-CoA-Tat potently inhibits GOAT in vitro, in cultured cells, and in mice. Intraperitoneal administration of GO-CoA-Tat improves glucose tolerance and reduces weight gain in wild-type mice but not in ghrelin-deficient mice, supporting the concept that its beneficial metabolic effects are due specifically to GOAT inhibition. In addition to serving as a research tool for mapping ghrelin actions, GO-CoA-Tat may help pave the way for clinical targeting of GOAT in metabolic diseases.

    Original languageEnglish (US)
    Pages (from-to)1689-1692
    Number of pages4
    Issue number6011
    StatePublished - Dec 17 2010

    ASJC Scopus subject areas

    • General


    Dive into the research topics of 'Glucose and weight control in mice with a designed ghrelin O-acyltransferase inhibitor'. Together they form a unique fingerprint.

    Cite this